Home  >  Speakers  >  Cliona M. Rooney
Cliona M. Rooney

Cliona M. Rooney

    PhD
Professor | Houston, Texas    United States of America
Oncology
Pediatrics, Hematology-Oncology,...More
Spoken at 2 events

Biography :

Dr. Cliona Rooney’s research interests are immunotherapies for virus and non-virus-associated malignancies and diseases. In protocols developed with Dr. Helen Heslop, Dr. Malcolm Brenner, Dr. Stephen Gottschalk and Dr. Catherine Bollard, about 150 patients have received EBV or antigen-specific cytotoxic T-cells. These have prevented and cured EBV-associated lymphoma in BMT recipients produced mixed tumor responses, including complete remissions in patients with relapsed EBV-positive Hodgkin’s disease and nasopharyngeal carcinoma and have produced clinical remission in chronic-active EBV infections.

In the research laboratory, she is developing methods for the activation and expansion of antigen-specific CTLs for the treatment of non-viral cancers, investigating ways to render CTL resistant to immune evasion strategies used by tumor cells to grow in an immunocompetent host and developing means to induce antigen-specific tolerance.

***************************
************
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Oncology

Interested Topics

Pediatrics, Hematology-Oncology, Molecular Virology, Microbiology, Immunology, Immunotherapies for Virus and Non-Virus-Associated Malignancies, EBV, Antigen-Specific Cytotoxic T-cells, Treatment of Non-Viral Cancers, Induction of Antigen-Specific Tolerance

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
X

Send Message

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.